Our plain-English summary of China and the US: asbestos in common, by A.L. Frank (International Journal of Occupational and Environmental Health, 2012).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Author: A.L. Frank
- Journal: International Journal of Occupational and Environmental Health
- Published: 2012;18(3):179-80
- Type of article: Editorial, Comment
- Cited by: 1 article, as counted by NIH iCite
- Read it: PubMed · Publisher
In plain English
This article was an editorial, an opinion piece, not a research study, and it reported no new data. The author commented on asbestos use in China and the United States. The editorial introduced a review of asbestos use and asbestos-related disease in China by Wang and colleagues, published in the same journal issue. The author stated that over 50 countries had banned asbestos entirely, while both the United States and China still allowed asbestos products. The author wrote that China used a bit over 600 000 tons of asbestos per year, rivaling United States use of some 775 000 tons a year in the early 1970s. The author noted that asbestos disease had declined in countries that stopped using asbestos. According to the author, disease data collection in China had been spotty at best, and China had no current useful compensation system for workers made ill. The author also noted that the US EPA's 1989 asbestos ban was overturned by a federal court two years later. The author concluded that, without a concerted effort to measure asbestos-related disease in China and India, its toll may never truly be known.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Editorial (opinion piece); no original research or data
- Who was studied: No people were studied. The editorial discusses asbestos use in China and the United States and introduces a review by Wang et al. in the same issue.
- Exposure: Continued use of asbestos, including chrysotile (the serpentine form) and the amphiboles, in China and the United States
- Main results:
- The author stated that over 50 countries have totally banned asbestos, while the United States and China continue to allow asbestos products
- The author stated that China uses a bit over 600 000 tons of asbestos per year, rivaling United States use of some 775 000 tons annually in the early 1970s
- The author stated that asbestos disease has declined in countries that discontinued its use
- The author stated that collection of disease data in China has been spotty at best
- The author stated that China has no current useful system of compensation for workers made ill by asbestos
- The author stated that the US EPA's 1989 asbestos ban was overturned by a federal court two years later
- The authors' conclusion: The author concluded that unless there is a concerted effort to determine the extent of asbestos-related disease in China and other industrializing countries such as India, the toll asbestos will take there may never truly be known, noting that the absence of data does not mean the absence of disease.
Topics
The National Library of Medicine indexes this study under subjects our site covers: Asbestosis, Lung cancer, Mesothelioma.
Related studies
- Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids — F. López-Ríos, P.B. Illei, et al. (2004)
- Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases — M. Miettinen, Z. Wang, et al. (2015)
- Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies — K. Sheahan, M.J. O'Brien, et al. (1990)
- Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases — J. Fukuoka, T.J. Franks, et al. (2005)
- p53 expression is common in malignant mesothelioma — G. Kafiri, D.M. Thomas, et al. (1992)
- Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration — A.C. Borczuk, J. Pei, et al. (2016)
Browse more research in International Journal of Occupational and Environmental Health, or return to medical research.
Cited on this site
How to cite it
Cite the study
A.L. Frank. China and the US: asbestos in common. International Journal of Occupational and Environmental Health 2012;18(3):179-80. doi:10.1179/1077352512Z.00000000032. PMID: 23026002.
Cite our summary
“China and the US: asbestos in common.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/china-and-the-us-asbestos-in-common.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.